Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Q: How can investors access Lantheus (LNTH) Morgan Stanley conference presentation?

Investors can access the live webcast through the Investors section of Lantheus.com . A replay will be available for at least 30 days after the presentation.

Q: Who will represent Lantheus (LNTH) at the Morgan Stanley Healthcare Conference?

Brian Markison , Chief Executive Officer of Lantheus, will represent the company at the conference.

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference. CEO Brian Markison will deliver a presentation on Tuesday, September 9, at 7:00 a.m. ET.

Investors and interested parties can access the live webcast through the Investors section of Lantheus.com. The presentation recording will remain available on the company's website for a minimum of 30 days following the live event.

News Market Reaction 1 Alert

+0.71% News Effect

On the day this news was published, LNTH gained 0.71%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

09/02/2025 - 08:30 AM

BEDFORD, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Morgan Stanley 23^rd Annual Global Healthcare Conference at 7:00 a.m. ET on Tuesday, September 9.

To access the live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden and Switzerland, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.

Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com

FAQ

When is Lantheus (LNTH) presenting at the Morgan Stanley Healthcare Conference 2025?

Lantheus CEO Brian Markison will present at the conference on Tuesday, September 9, 2025, at 7:00 a.m. ET.

How can investors access Lantheus (LNTH) Morgan Stanley conference presentation?

Investors can access the live webcast through the Investors section of Lantheus.com. A replay will be available for at least 30 days after the presentation.